293 related articles for article (PubMed ID: 17882547)
21. Bronchial epithelial compression regulates epidermal growth factor receptor family ligand expression in an autocrine manner.
Chu EK; Foley JS; Cheng J; Patel AS; Drazen JM; Tschumperlin DJ
Am J Respir Cell Mol Biol; 2005 May; 32(5):373-80. PubMed ID: 15705969
[TBL] [Abstract][Full Text] [Related]
22. Activation of a nuclear factor kappaB/interleukin-1 positive feedback loop by amphiregulin in human breast cancer cells.
Streicher KL; Willmarth NE; Garcia J; Boerner JL; Dewey TG; Ethier SP
Mol Cancer Res; 2007 Aug; 5(8):847-61. PubMed ID: 17670913
[TBL] [Abstract][Full Text] [Related]
23. Role of epidermal-growth-factor receptor in tumor progression in transformed human mammary epithelial cells.
Ma L; Gauvillé C; Berthois Y; Degeorges A; Millot G; Martin PM; Calvo F
Int J Cancer; 1998 Sep; 78(1):112-9. PubMed ID: 9724102
[TBL] [Abstract][Full Text] [Related]
24. Targeting TACE-dependent EGFR ligand shedding in breast cancer.
Kenny PA; Bissell MJ
J Clin Invest; 2007 Feb; 117(2):337-45. PubMed ID: 17218988
[TBL] [Abstract][Full Text] [Related]
25. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.
Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L
PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521
[TBL] [Abstract][Full Text] [Related]
26. Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo.
Nickerson NK; Mill CP; Wu HJ; Riese DJ; Foley J
Oncol Res; 2013; 20(7):303-17. PubMed ID: 23879171
[TBL] [Abstract][Full Text] [Related]
27. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
[TBL] [Abstract][Full Text] [Related]
28. Validation of HB-EGF and amphiregulin as targets for human cancer therapy.
Yotsumoto F; Yagi H; Suzuki SO; Oki E; Tsujioka H; Hachisuga T; Sonoda K; Kawarabayashi T; Mekada E; Miyamoto S
Biochem Biophys Res Commun; 2008 Jan; 365(3):555-61. PubMed ID: 18023415
[TBL] [Abstract][Full Text] [Related]
29. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells.
Gschwind A; Hart S; Fischer OM; Ullrich A
EMBO J; 2003 May; 22(10):2411-21. PubMed ID: 12743035
[TBL] [Abstract][Full Text] [Related]
30. The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types.
Johansson CC; Yndestad A; Enserink JM; Ree AH; Aukrust P; Taskén K
Endocrinology; 2004 Nov; 145(11):5177-84. PubMed ID: 15284208
[TBL] [Abstract][Full Text] [Related]
31. Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate.
Adam RM; Borer JG; Williams J; Eastham JA; Loughlin KR; Freeman MR
Endocrinology; 1999 Dec; 140(12):5866-75. PubMed ID: 10579352
[TBL] [Abstract][Full Text] [Related]
32. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
33. Activation of epidermal growth factor receptor during corneal epithelial migration.
Zieske JD; Takahashi H; Hutcheon AE; Dalbone AC
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1346-55. PubMed ID: 10798649
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells.
Sehgal I; Bailey J; Hitzemann K; Pittelkow MR; Maihle NJ
Mol Biol Cell; 1994 Mar; 5(3):339-47. PubMed ID: 8049525
[TBL] [Abstract][Full Text] [Related]
35. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells.
Willmarth NE; Ethier SP
J Biol Chem; 2006 Dec; 281(49):37728-37. PubMed ID: 17035230
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells.
Eckstein N; Servan K; Girard L; Cai D; von Jonquieres G; Jaehde U; Kassack MU; Gazdar AF; Minna JD; Royer HD
J Biol Chem; 2008 Jan; 283(2):739-50. PubMed ID: 17942395
[TBL] [Abstract][Full Text] [Related]
37. Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines.
Sanders JL; Chattopadhyay N; Kifor O; Yamaguchi T; Butters RR; Brown EM
Endocrinology; 2000 Dec; 141(12):4357-64. PubMed ID: 11108243
[TBL] [Abstract][Full Text] [Related]
38. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
Hutcheson IR; Knowlden JM; Madden TA; Barrow D; Gee JM; Wakeling AE; Nicholson RI
Breast Cancer Res Treat; 2003 Sep; 81(1):81-93. PubMed ID: 14531500
[TBL] [Abstract][Full Text] [Related]
39. Exosome-bound WD repeat protein Monad inhibits breast cancer cell invasion by degrading amphiregulin mRNA.
Saeki M; Egusa H; Kamano Y; Kakihara Y; Houry WA; Yatani H; Noguchi S; Kamisaki Y
PLoS One; 2013; 8(7):e67326. PubMed ID: 23844004
[TBL] [Abstract][Full Text] [Related]
40. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
Liu X; Carlisle DL; Swick MC; Gaither-Davis A; Grandis JR; Siegfried JM
Exp Cell Res; 2007 Apr; 313(7):1361-72. PubMed ID: 17349623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
